A phase II trial of trastuzumab combined with irinotecan in patients with advanced HER2-positive chemo-refractory gastric cancer: OGSG1203 (HERBIS-5).

标题
A phase II trial of trastuzumab combined with irinotecan in patients with advanced HER2-positive chemo-refractory gastric cancer: OGSG1203 (HERBIS-5).
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 34, Issue 4_suppl, Pages 128-128
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2017-02-24
DOI
10.1200/jco.2016.34.4_suppl.128

向作者/读者发起求助以获取更多资源

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started